HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fei Xie Selected Research

matrigel

3/2016Overexpression of miR-30a in lung adenocarcinoma A549 cell line inhibits migration and invasion via targeting EYA2.
8/2015Mucin1 promotes the migration and invasion of hepatocellular carcinoma cells via JNK-mediated phosphorylation of Smad2 at the C-terminal and linker regions.
4/2014miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma.
4/2010Expression of bone morphogenetic protein 7 in lung cancer and its biological impact on lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fei Xie Research Topics

Disease

84Neoplasms (Cancer)
05/2024 - 01/2011
23Breast Neoplasms (Breast Cancer)
07/2023 - 03/2008
18Hepatocellular Carcinoma (Hepatoma)
05/2024 - 03/2014
14Neoplasm Metastasis (Metastasis)
05/2024 - 01/2011
14Inflammation (Inflammations)
09/2023 - 07/2015
13Urinary Bladder Neoplasms (Bladder Cancer)
05/2024 - 01/2017
9Infections
02/2024 - 10/2012
9Sepsis (Septicemia)
11/2023 - 02/2016
9Lung Neoplasms (Lung Cancer)
01/2023 - 04/2010
9Ischemia
11/2022 - 01/2014
8Atherosclerosis
02/2023 - 01/2017
7Squamous Cell Carcinoma of Head and Neck
08/2023 - 06/2020
6COVID-19
12/2024 - 01/2021
6Hypoxia (Hypoxemia)
02/2024 - 01/2015
6Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 12/2019
6Carcinogenesis
01/2022 - 03/2014
6Stroke (Strokes)
12/2021 - 05/2017
5Alzheimer Disease (Alzheimer's Disease)
12/2023 - 12/2021
5Pathologic Processes
12/2023 - 01/2017
5Wounds and Injuries (Trauma)
09/2023 - 09/2017
5Necrosis
09/2023 - 07/2015
5Pneumonia (Pneumonitis)
01/2023 - 01/2017
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 06/2017
5Shock
12/2022 - 05/2010
5Brain Injuries (Brain Injury)
11/2022 - 01/2015
5Lymphatic Metastasis
10/2022 - 09/2010
5Ischemic Stroke
07/2022 - 01/2019
5Hepatitis B
01/2022 - 03/2014
5Atrial Fibrillation
03/2019 - 01/2015
5Adenocarcinoma
03/2019 - 07/2013
4Lung Injury
03/2024 - 09/2017
4Acute Lung Injury
12/2022 - 06/2020
4Brain Ischemia (Cerebral Ischemia)
08/2022 - 01/2014
4Hyperglycemia
01/2022 - 01/2009
4Infarction (Infarctions)
01/2019 - 01/2014
3Carcinoma (Carcinomatosis)
05/2024 - 12/2015
3Cognitive Dysfunction
02/2024 - 12/2022
3Diabetes Mellitus
12/2023 - 10/2021
3Metabolic Diseases (Metabolic Disease)
04/2023 - 01/2020
3Ovarian Neoplasms (Ovarian Cancer)
04/2023 - 01/2020
3Parkinson Disease (Parkinson's Disease)
01/2023 - 01/2017
3Obesity
01/2023 - 01/2020
3Body Weight (Weight, Body)
01/2023 - 10/2020
3Hypertension (High Blood Pressure)
06/2022 - 05/2017
3Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 04/2017
3Glioma (Gliomas)
03/2022 - 01/2013

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
03/2024 - 04/2010
13Long Noncoding RNAIBA
01/2024 - 04/2017
13MicroRNAs (MicroRNA)IBA
01/2024 - 03/2016
11Circular RNAIBA
10/2023 - 01/2017
10Biomarkers (Surrogate Marker)IBA
01/2024 - 03/2008
9RNA (Ribonucleic Acid)IBA
11/2022 - 01/2017
9DNA (Deoxyribonucleic Acid)IBA
11/2021 - 10/2012
9salicylhydroxamic acid (SHAM)IBA
01/2019 - 01/2014
8Messenger RNA (mRNA)IBA
01/2021 - 01/2015
7Reactive Oxygen Species (Oxygen Radicals)IBA
09/2023 - 10/2017
7EnzymesIBA
04/2023 - 01/2015
6AlbuminsIBA
12/2023 - 09/2020
6Small Interfering RNA (siRNA)IBA
10/2023 - 12/2010
6HydrogenIBA
06/2023 - 01/2019
6Therapeutic UsesIBA
01/2023 - 10/2017
5Immunoconjugates (Immunoconjugate)IBA
01/2022 - 07/2019
5Mucin-1 (CA 15-3 Antigen)IBA
03/2017 - 07/2013
4SmokeIBA
03/2024 - 09/2017
4ErbB Receptors (EGF Receptor)IBA
06/2023 - 02/2013
4Paclitaxel (Taxol)FDA LinkGeneric
04/2023 - 01/2019
4Cisplatin (Platino)FDA LinkGeneric
01/2023 - 10/2021
4Immune Checkpoint InhibitorsIBA
01/2023 - 01/2020
4LipidsIBA
01/2023 - 01/2017
4LipopolysaccharidesIBA
01/2023 - 01/2017
4Streptozocin (Streptozotocin)FDA Link
11/2022 - 01/2009
4Estrogen ReceptorsIBA
10/2022 - 10/2021
4Oxygen (Dioxygen)IBA
05/2022 - 01/2015
4CytokinesIBA
02/2022 - 01/2018
4NF-kappa B (NF-kB)IBA
02/2022 - 01/2017
4Cholinergic ReceptorsIBA
01/2019 - 07/2016
4matrigelIBA
03/2016 - 04/2010
3zinc chlorideFDA Link
03/2024 - 09/2017
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
12/2023 - 11/2017
3BilirubinIBA
06/2023 - 09/2020
3Hormones (Hormone)IBA
06/2023 - 04/2021
3AntioxidantsIBA
04/2023 - 01/2017
3Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
04/2023 - 04/2022
3Adenosine Triphosphate (ATP)IBA
01/2023 - 02/2019
3Volatile Fatty AcidsIBA
01/2023 - 01/2020
3Epirubicin (Ellence)FDA LinkGeneric
12/2022 - 10/2018
3Docetaxel (Taxotere)FDA Link
12/2022 - 10/2018
3heparanaseIBA
11/2022 - 01/2017
3Estrogens (Estrogen)FDA Link
08/2022 - 10/2021
3Neuroprotective AgentsIBA
08/2022 - 01/2015

Therapy/Procedure

35Therapeutics
05/2024 - 12/2010
16Drug Therapy (Chemotherapy)
07/2023 - 03/2008
8Immunotherapy
05/2024 - 07/2013
7Transplantation
09/2023 - 01/2009
6Radiotherapy
07/2023 - 02/2013
6Neoadjuvant Therapy
06/2023 - 10/2018
5Cardiopulmonary Bypass (Heart-Lung Bypass)
01/2022 - 10/2018
4Hepatectomy
12/2023 - 11/2021
3Critical Care (Surgical Intensive Care)
01/2024 - 10/2020
3Adjuvant Chemotherapy
06/2023 - 10/2018